drugset / Trial / NCT07660406

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

NCT07660406

Phase 1/2 Recruiting 30 enrolled Peking Union Medical College Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

Keloids are often described as benign dermal fibroproliferative lesions characterized by increased growth beyond the boundaries of the original wound margin.Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars. Thus this prospective study is going to investigate whether 68Ga-RGD PET/CT may provide evidence for diagnosis and evaluate the effectiveness of treatment.

Timeline

Start
2024-08-01
Primary completion
2024-10-23
Completion
2027-10

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-RGD Diagnostic / imaging agent 18.5 mbq/kg Intravenous
Subject 68Ga-RGD Diagnostic / imaging agent 22.2 mbq/kg Intravenous

Indications